This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Immune Thrombocytopenia (ITP) Immune-Genetic Assessment (UNIT)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by Azienda Sanitaria-Universitaria Integrata di Udine.
Recruitment status was:  Not yet recruiting
Information provided by:
Azienda Sanitaria-Universitaria Integrata di Udine Identifier:
First received: September 7, 2010
Last updated: September 8, 2010
Last verified: September 2010

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Azienda Sanitaria-Universitaria Integrata di Udine:

Estimated Enrollment: 190
Study Start Date: September 2010
Asymptomatic ITP patients
ITP patients treated with Rituximab
ITP patients treated with steroids


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Primary care clinic

Inclusion Criteria:

  • Adult patients with primary ITP

Exclusion Criteria:

  • Secondary ITP
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01196884

Contact: Francesco Zaja, MD +39 0432 559604

Istituto di Ematologia L. & A. Seragnoli Not yet recruiting
Bologna, Italy, 40100
Contact: Nicola Vianelli, MD         
Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco Not yet recruiting
Cagliari, Italy, 09100
Contact: Emilio Usala, MD         
UF Ematologia, Policlinico di Careggi Not yet recruiting
Firenze, Italy
Contact: Antonella Gozzini, MD         
U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico Not yet recruiting
Milano, Italy, 20122
Contact: Wilma Barcellini, MD         
Department of Oncology/Haematology, Niguarda Ca'Granda Hospital Not yet recruiting
Milano, Italy
Contact: Silvia Cantoni, MD         
Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro Not yet recruiting
Novara, Italy, 28100
Contact: Gianluca Gaidano, Prof.         
Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro" Not yet recruiting
Novara, Italy, 28100
Contact: Umberto Dianzani, Prof.         
Department of Medical and Surgical Sciences, University of Padova Not yet recruiting
Padova, Italy, 35100
Contact: Fabrizio Fabris, Prof.         
Oncology-Hematology Department, "S. Maria delle Croci" Hospital Not yet recruiting
Ravenna, Italy, 48121
Contact: Alfonso Zaccaria, MD         
Institute of Hematology, Catholic University, Not yet recruiting
Roma, Italy, 00168
Contact: Valerio De Stefano, MD         
Ematologia, Ospedale Ca' Foncello Not yet recruiting
Treviso, Italy, 31100
Contact: Filippo Gherlinzoni, MD         
Clinica Ematologica AOUD S. Maria Misericordia Not yet recruiting
Udine, Italy, 33100
Contact: Francesco Zaja, MD    +39 0432559604   
Principal Investigator: Francesco Zaja, MD         
Ematologia, San Bortolo Hospital Not yet recruiting
Vicenza, Italy, 36100
Contact: Francesco Rodeghiero, Prof.         
Sponsors and Collaborators
Azienda Sanitaria-Universitaria Integrata di Udine
  More Information

Responsible Party: Francesco Zaja, Clinica Ematologica, Azienda Ospedaliero Universitaria S. Maria Misericordia di Udine Identifier: NCT01196884     History of Changes
Other Study ID Numbers: UNIT
Study First Received: September 7, 2010
Last Updated: September 8, 2010

Keywords provided by Azienda Sanitaria-Universitaria Integrata di Udine:
Patients with primary Immune Thrombocytopenia (ITP)

Additional relevant MeSH terms:
Purpura, Thrombocytopenic, Idiopathic
Blood Platelet Disorders
Hematologic Diseases
Purpura, Thrombocytopenic
Blood Coagulation Disorders
Thrombotic Microangiopathies
Hemorrhagic Disorders
Autoimmune Diseases
Immune System Diseases
Pathologic Processes
Skin Manifestations
Signs and Symptoms processed this record on September 21, 2017